229 related articles for article (PubMed ID: 19095348)
1. Stem cells in melanoma development.
Sabatino M; Stroncek DF; Klein H; Marincola FM; Wang E
Cancer Lett; 2009 Jul; 279(2):119-25. PubMed ID: 19095348
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells and human malignant melanoma.
Schatton T; Frank MH
Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.
Kong Y; Kumar SM; Xu X
Arch Pathol Lab Med; 2010 Dec; 134(12):1740-9. PubMed ID: 21128770
[TBL] [Abstract][Full Text] [Related]
4. MITF pathway mutations in melanoma.
Yokoyama S; Salma N; Fisher DE
Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
[No Abstract] [Full Text] [Related]
5. Molecular pathogenesis of cutaneous melanocytic neoplasms.
Ibrahim N; Haluska FG
Annu Rev Pathol; 2009; 4():551-79. PubMed ID: 19400696
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in melanocyte senescence and melanoma transformation.
Meierjohann S
Eur J Cell Biol; 2014; 93(1-2):36-41. PubMed ID: 24342719
[TBL] [Abstract][Full Text] [Related]
7. Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells.
Moon H; Donahue LR; Kim D; An L; White AC
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31233013
[TBL] [Abstract][Full Text] [Related]
8. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
9. [Role of cancer stem cells in the progression and heterogeneity of melanoma].
Széky B; Silló P; Fábián M; Mayer B; Kárpáti S; Németh K
Orv Hetil; 2016 Aug; 157(34):1339-48. PubMed ID: 27546799
[TBL] [Abstract][Full Text] [Related]
10. TGF-β may control the switch between tumorigenic growth and "stem cell/mesenchymal" potentially drug-resistant states.
Bordelon JR; Grichnik JM
Dermatol Ther; 2015; 28(3):177-8. PubMed ID: 25649199
[No Abstract] [Full Text] [Related]
11. Tumor initiation in human malignant melanoma and potential cancer therapies.
Ma J; Frank MH
Anticancer Agents Med Chem; 2010 Feb; 10(2):131-6. PubMed ID: 20184545
[TBL] [Abstract][Full Text] [Related]
12. Met amplification and tumor progression in Cdkn2a-deficient melanocytes.
Vanbrocklin MW; Robinson JP; Whitwam T; Guilbeault AR; Koeman J; Swiatek PJ; Vande Woude GF; Khoury JD; Holmen SL
Pigment Cell Melanoma Res; 2009 Aug; 22(4):454-60. PubMed ID: 19422607
[TBL] [Abstract][Full Text] [Related]
13. Malignant melanoma: diagnosis, treatment and cancer stem cells.
Kozovska Z; Gabrisova V; Kucerova L
Neoplasma; 2016; 63(4):510-7. PubMed ID: 27268913
[TBL] [Abstract][Full Text] [Related]
14. Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?
Brinckerhoff CE
J Cell Physiol; 2017 Oct; 232(10):2674-2678. PubMed ID: 28078710
[TBL] [Abstract][Full Text] [Related]
15. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
16. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X
Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934
[TBL] [Abstract][Full Text] [Related]
17. The roles of microphthalmia-associated transcription factor and pigmentation in melanoma.
Hsiao JJ; Fisher DE
Arch Biochem Biophys; 2014 Dec; 563():28-34. PubMed ID: 25111671
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species: an Achilles' heel of melanoma?
Fruehauf JP; Trapp V
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1751-7. PubMed ID: 18983235
[TBL] [Abstract][Full Text] [Related]
20. A novel mouse model demonstrates that oncogenic melanocyte stem cells engender melanoma resembling human disease.
Sun Q; Lee W; Mohri Y; Takeo M; Lim CH; Xu X; Myung P; Atit RP; Taketo MM; Moubarak RS; Schober M; Osman I; Gay DL; Saur D; Nishimura EK; Ito M
Nat Commun; 2019 Nov; 10(1):5023. PubMed ID: 31685822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]